Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
Typhoid is a public health problem in Nepal. To generate evidence on the impact of Typhoid Conjugate Vaccine (TCV), a phase 3, double-blind, randomized controlled trial was conducted in Lalitpur, Nepal. 20,000 children aged between 9 months and ≤16 years were vaccinated with a new TCV, or control va...
Main Authors: | Dahal, A, Shakya, M, Pant, D, Adhikari, A, Colin-Jones, R, Theiss-Nyland, K, Pollard, AJ, Basnyat, B, Shrestha, S |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Taylor and Francis
2022
|
Podobne knjige/članki
-
Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal
od: Shakya, M
Izdano: (2022) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
od: Shakya, M, et al.
Izdano: (2019) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
od: Shakya, M, et al.
Izdano: (2019) -
Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal
od: Colin-Jones, R, et al.
Izdano: (2019) -
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
od: Shakya, M, et al.
Izdano: (2021)